CD200 and Lymphadenopathy: Compared with patients with CD200-negative MCL, those with CD200 + MCL are more likely to have non-nodal leukemic presentation characterized by the loss of lymphadenopathy or extranodal and/or gastrointestinal tract disease [10, 31].